Working with Bohr

Almost since I can remember, my ambition was to be a physicist. My parents had both studied physics and worked for a short time in the Cavendish Laboratory, and, although neither made a career in science, I was brought up knowing about physics. At both preparatory and secondary schools, however, my most inspiring teachers taught mathematics, and I left school with a maths scholarship to Cambridge and the ambition to work on quantum theory. That was in 1923, when Sommerfeld and others were still

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Almost since I can remember, my ambition was to be a physicist. My parents had both studied physics and worked for a short time in the Cavendish Laboratory, and, although neither made a career in science, I was brought up knowing about physics. At both preparatory and secondary schools, however, my most inspiring teachers taught mathematics, and I left school with a maths scholarship to Cambridge and the ambition to work on quantum theory. That was in 1923, when Sommerfeld and others were still elaborating Niels Bohr's theory of orbits.

But in 1926, when I took my final examination-which included some questions on quantum theory-the "new" quantum mechanics of Heisenberg and Schrodinger appeared and everything was changed. Bohr's orbits were dead. Most of physics and all of chemistry were now open to the theorist, once he or she could understand the new theory.

But there was no one in Cambridge ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Nevill Mott

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio 
Zymo Research

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences